catalyzed to 24,25(OH) 2 D in CRF, probably largely via extrareSerum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitanal 24-hydroxylase. Serum levels of 1,25(OH) 2 D were signifimin D, and 25-hydroxyvitamin D in nondialyzed patients with cantly affected by the degree of renal failure. Thus, this study chronic renal failure.
abnormalities in electrolyte metabolism is an imbalance whom had diabetes mellitus (DM-CRF) and 39 of whom were of calcium and phosphate, the metabolism of which is nondiabetic (nonDM-CRF).
Results. Serum levels of 1,25(OH) 2 33] . method, in which ϩ, ϩ ϩ, and ϩ ϩ ϩ levels represented
The clinical characteristics of nonDM-CRF and DMurinary protein levels of approximately 30 to 100 mg/dl, CRF patients are summarized in Table 1 . 100 to 300 mg/dl, and Ͼ300 mg/dl, respectively. After Extraction and assay of the three serum was separated, 2 ml was frozen and stored at vitamin D metabolites Ϫ40ЊC, and levels of 25(OH)D, 24,25(OH) 2 D and 1,25(OH) 2 D were measured. The rest of the serum was
The three vitamin D metabolites were extracted and used to measure levels of creatinine, albumin, calcium, assayed for their serum levels by Mitsubishi Kagaku Biophosphate and parathyroid hormone (PTH). Serum creChemical Laboratory (Tokyo, Japan). The methods are atinine, albumin, calcium and phosphate were measured described in detail in a previous report [36] . In brief, by an autoanalyzer. Serum calcium concentrations were 2000 dpm of 1,25(OH) 2 (Millipore, Milford, MA, USA). Lipid extracts con-
taining vitamin D metabolites were automatically eluted Serum concentrations of PTH were measured with a kit with 6 ml of acetonitrile. After the elutes evaporated, (Allegro intact PTH kit; Japan MediPhysics Inc., Tokyo, the samples were resuspended in toluene/ethanol (liter/ Japan) that recognizes an intact molecule of PTH [31] .
liter) and stored at Ϫ80ЊC until assayed. The reference range of PTH in healthy subjects was 10 Samples were dried under nitrogen and resuspended to 65 pg/ml. Hemoglobin A1C of diabetic patients was in 300 ml of methanol/isopropanol/N-hexane (1/6/93). measured by high performance liquid chromatography.
Vitamin D metabolites were separated by high pressure liquid chromatography (HPLC) [37] with a model 0.46 ϫ In men, creatinine clearance (C Cr ) was estimated ac- Correlations between each vitamin D mewas 16.9 Ϯ 9.4 ng/ml, which was not significantly different tabolite and estimated C Cr are shown in Figure 1 . Alfrom the reference range for healthy controls. The mean though there were no significant associations between serum level of 24,25(OH) 2 D was 0.59 Ϯ 0.38 ng/ml, which serum corrected calcium levels and each vitamin D mewas significantly lower than the reference range for tabolite, there were significant, negative correlations behealthy controls (P Ͻ 0.01). The mean serum level of tween serum phosphate levels and each vitamin D me-1,25(OH) 2 D was 18.8 Ϯ 9.2 pg/ml, which was significantly tabolite. There were also significant, positive correlations lower than the reference range for healthy controls between serum albumin and each vitamin D metabolite. (P Ͻ 0.0001). Serum levels of the three vitamin D metWith respect to interrelationships among the three vitaabolites in nonDM-CRF and DM-CRF are shown in min D metabolites, there were strong, significant, posi- There was no those in nonDM-CRF (P Ͻ 0.0001, P Ͻ 0.001 and P Ͻ significant correlation between age and each vitamin D 0.002, respectively). There were no significant betweenmetabolite. group differences in age, sex, body weight, body mass
Because the clinical parameters that correlated with index, serum creatinine, estimated C Cr , BUN, corrected vitamin D metabolites were also interrelated, multiple calcium, phosphate, and serum intact PTH, although seregression analyses were performed to assess the comrum albumin and fasting blood glucose were significantly bined influence of these factors on serum levels of the lower in DM-CRF than nonDM-CRF (P Ͻ 0.005 and three vitamin D metabolites. A model including serum P Ͻ 0.001, respectively). Semiquantitative assessment of albumin, presence of DM, phosphate, estimated C Cr and urinary protein revealed significantly higher levels in serum PTH as independent variables was used to analyze DM-CRF patients than in nonDM-CRF patients (P Ͻ 0.001).
the combined influence of these factors on serum GK rats [23, 24, 26, 28, 49] . In these animal models, in nonDM-CRF. Considering that vitamin D metabolites 25(OH)D 1␣-hydroxylase and 24-hydroxylase activities are mostly bound to vitamin D-binding proteins, whose appear to be impaired [23, 24, 50] . In human studies, serum levels are closely associated with serum albumin however, different results with respect to serum levels levels [1] [2] [3] 53] , serum albumin may be strongly associof 25(OH)D, 24,25(OH) 2 D and 1,25(OH) 2 D have been ated with serum levels of vitamin D metabolites. Signifireported; specifically, serum levels of vitamin D metabocant positive correlations between serum albumin and lites differ between diabetics and control subjects [25, the three vitamin D metabolites in our study also support 27-29, 51]. Reduced serum levels of 1,25(OH) 2 D in diathis speculation. The more exaggerated hypoalbumibetics were reported in some studies but not in others.
nemia in DM-CRF in the present study was presumably While these studies examined subjects with normal renal caused primarily by significantly higher excretion of urifunction, there have been few reports in which vitamin nary protein. Furthermore, other factors such as malnu-D metabolite levels were examined in patients with DMtrition in DM-CRF may contribute to hypoalbuminemia. CRF [13, 52] . In our study, all three vitamin D metabolite Hemoglobin levels, one of the indices of nutritional status, levels were significantly lower in DM-CRF than in were lower in DM-CRF than in nonDM-CRF (10.4 Ϯ nonDM-CRF, despite the fact that there were no signifi-1.6 g/dl vs. 11.2 Ϯ 1.9 g/dl, P Ͻ 0.05) even though some cant differences in age, sex, body weight, corrected calpatients with anemia in both the DM-CRF and nonDMcium, phosphate or PTH levels. Our results contradict CRF groups were receiving erythropoietin therapy, as those of Lu et al [13] , which showed no significant differwe recently reported [54] . Therefore, the significantly ence in serum 25(OH)D and 1,25(OH) 2 D between DMlower serum levels of all three vitamin D metabolites in CRF and nonDM-CRF, although 25(OH)D levels had DM-CRF than in nonDM-CRF in our study may have a tendency to be lower in DM-CRF. In our study, serum albumin levels were significantly lower in DM-CRF than been caused by significantly decreased serum albumin precursor that has little hormonal function, are not tightly or feedback controlled, and are independent of We speculate that another contributing factor may have been impaired intestinal absorption of vitamin D in diathe free/total ratio of 1,25(OH) 2 D, which acts as a tightly regulated hormone. Thus, low 25(OH)D levels in pabetic patients, since patients with advanced diabetic nephropathy often have gastroenteropathy associated with tients in the present study suggest the presence of hypovitaminosis D. However, since serum concentrations of diabetic autonomic neuropathy [59, 60] . Furthermore, diabetic patients with nephropathy may be sicker than total and free 1,25(OH) 2 D decrease with a high degree of correlation as renal function declines in CRF patients nonDM-CRF patients in terms of hypoalbuminemia (more frequent presence of nephrotic syndrome), leadand free 1,25(OH) 2 D falls as glomerular filtration rate decreases in nephrotic patients [18] , the reduced levels ing to less outside activity and sunlight exposure necessary for synthesizing vitamin D; however, outside activity of total 1,25(OH) 2 D in our study may reflect reduced free 1,25(OH) 2 D levels, leading to a deficiency in the was not assessed in the present study. Multiple regression analysis to evaluate serum levels of 24,25(OH) 2 D demonactive form of vitamin D in CRF.
In the present study, PTH levels in DM-CRF patients strated that 24,25(OH) 2 D levels were strongly and positively associated with 25(OH)D. 25(OH)D 24-hydroxywere not significantly different from those of nonDM-CRF patients. Among patients receiving hemodialysis lase is reported to be activated by an excessive amount of 25(OH)D and represents the catabolic pathway of or peritoneal dialysis, PTH levels have been reported to be lower in those with diabetes than those without; vitamin D [1-3, 15, 19] . Even though renal 25(OH)D 24-hydroxylase activity may be reduced in chronic renal however, few studies have compared the effect of diabetes on PTH levels in predialysis patients with renal failure failure [18, 61] , the results of the present study suggest that 25(OH)D 24-hydroxylase can be activated as serum [63] [64] [65] [66] . In rats with streptozotocin-induced diabetes and azotemia, PTH levels were not significantly different substrate [25(OH)D] levels increase. This speculation is consistent with the results of animal and human studies from those in nondiabetic azotemic rats, although indices of bone turnover rate were lower in the former than in of renal failure [19, 46, 62] , in which 24,25(OH) 2 D levels correlated with 25(OH)D levels after 25(OH)D administhe latter [67] . In a clinical study, Fajtova et al reported
